Published in Clin Chem on March 01, 1983
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature (2015) 5.15
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol (2006) 3.37
Collective review of small carcinomas of the pancreas. Ann Surg (1986) 2.24
Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol (1984) 1.98
Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer. Br J Cancer (1986) 1.91
Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases. Br J Cancer (1984) 1.56
Prognostic value of serum CA 19-9 levels in pancreatic adenocarcinoma. Ann Surg (1992) 1.55
Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis. Br J Cancer (1986) 1.45
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9. Br J Cancer (1992) 1.39
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer. Br J Cancer (2005) 1.34
Tumour markers: An overview. Indian J Clin Biochem (2007) 1.26
Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases. Br J Cancer (1991) 1.25
The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr Mol Med (2013) 1.21
Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9. Br J Cancer (1989) 1.18
Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg (1992) 1.13
Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer. Br J Cancer (1994) 1.11
AB0 blood group and prognosis in patients with pancreatic cancer. BMC Cancer (2012) 1.06
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA. Br J Cancer (1994) 1.03
CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone. Br J Cancer (2009) 0.98
Monoclonal antibody defines CA 19-9 in pancreatic juices and sera. Gut (1985) 0.98
Prognostic value of preoperative serum tumor markers in gastric cancer. World J Clin Oncol (2014) 0.96
Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype. Br J Cancer (1991) 0.95
The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer (1994) 0.95
Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma. Int J Clin Exp Pathol (2014) 0.90
Mirizzi syndrome caused by xanthogranulomatous cholecystitis: report of a case. Surg Today (1997) 0.89
Potentials of plasma NGAL and MIC-1 as biomarker(s) in the diagnosis of lethal pancreatic cancer. PLoS One (2013) 0.89
CA19-9 as a marker for ovarian cancer: alone and in comparison with CA125. Br J Cancer (1985) 0.88
Tumour associated antigens in diagnosis of serous effusions. J Clin Pathol (1988) 0.87
Serum biomarkers in interstitial lung diseases. Respir Res (2005) 0.85
Clinical utility of tumor marker cutoff ratio and a combination scoring system of preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 72-4 levels in gastric cancer. J Korean Surg Soc (2013) 0.84
CA 19-9 as a serum marker in urothelial carcinoma. Urol Ann (2012) 0.84
Expression of sialyl Lewis(a) relates to poor prognosis in cholangiocarcinoma. World J Gastroenterol (2005) 0.83
Comparative study of CA242 and CA19-9 in chronic pancreatitis. Br J Cancer (1996) 0.81
Carbohydrate antigen 19-9 is a valuable prognostic factor in colorectal cancer patients with normal levels of carcinoembryonic antigen and may help predict lung metastasis. Int J Colorectal Dis (2012) 0.80
Failure of CA19-9 to detect asymptomatic colorectal carcinoma. Br J Cancer (1991) 0.80
Biomarkers in pancreatic adenocarcinoma: current perspectives. Onco Targets Ther (2016) 0.79
Pancreatic Cancer Exosomes: Shedding Off for a Meaningful Journey. Pancreat Disord Ther (2016) 0.79
The diagnostic value of the foetoacinar pancreatic (FAP) protein in cancer of the pancreas; a comparative study with CA19/9. Br J Cancer (1987) 0.79
Is health screening beneficial for early detection and prognostic improvement in pancreatic cancer? Gut Liver (2011) 0.79
Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma. Int J Clin Exp Pathol (2015) 0.78
Detection of a circulating gastrointestinal cancer antigen in sera of patients with gastrointestinal malignancies by a double determinant immunoassay with monoclonal antibodies against human blood group determinants. Clin Exp Immunol (1984) 0.78
Vascular endothelial growth factor levels in ascites between chemonaive and chemotreated patients. Yonsei Med J (2008) 0.77
Preoperative serum levels of CEA and CA 242 in colorectal cancer. Br J Cancer (1995) 0.77
Differential gene expression analysis of peripheral blood mononuclear cells reveals novel test for early detection of pancreatic cancer. Cancer Biomark (2012) 0.77
Immunohistochemical staining of colorectal tissues with monoclonal antibodies to ras oncogene p21 product and carbohydrate determinant antigen 19-9. J Clin Pathol (1987) 0.76
Similarity and co-expression of tumour-associated antigens recognised by different monoclonal antibodies. Br J Cancer (1993) 0.75
Flow cytometric analysis of sialyl Lewis A antigen on human cancer cells by using F(ab')2μ fragments prepared from a mouse IgM monoclonal antibody. Cytotechnology (1997) 0.75
Double antibody radioimmunoassay for monitoring metastatic breast cancer. Br J Cancer (1988) 0.75
A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study. Am J Gastroenterol (2016) 0.75
Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochips. Cancer Med (2016) 0.75
Informativeness of Diagnostic Marker Values and the Impact of Data Grouping. Comput Stat Data Anal (2017) 0.75
Development of quantitative immunochromatographic assay for rapid and sensitive detection of carbohydrate antigen 19-9 (CA 19-9) in human plasma. J Pharm Biomed Anal (2017) 0.75
Nanoplasmonic Quantification of Tumor-derived Extracellular Vesicles in Plasma Microsamples for Diagnosis and Treatment Monitoring. Nat Biomed Eng (2017) 0.75
A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med (1983) 8.82
A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. JAMA (1995) 4.45
Recovery and management options for spring/summer chinook salmon in the Columbia River basin. Science (2000) 4.08
Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol (2001) 3.83
Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res (1992) 3.66
Characterization of the SV40 T antigen. Virology (1973) 3.22
Patterns of her-2/neu amplification and overexpression in primary and metastatic breast cancer. J Natl Cancer Inst (2001) 2.93
Cell type-specific activation of actin genes in the early amphibian embryo. Nature (1984) 2.91
Interaction of EGF receptor and grb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr Biol (2000) 2.79
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol (1992) 2.43
Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis. J Clin Microbiol (1999) 2.20
Evaluation of differential and selective media for isolation of Aeromonas and Plesiomonas spp. from human feces. J Clin Microbiol (1983) 2.16
Right hepatic lobe donation for living donor liver transplantation: impact on donor quality of life. Liver Transpl (2001) 2.06
Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer. J Clin Oncol (1986) 1.94
Detecting activation of ribosomal protein S6 kinase by complementary DNA and tissue microarray analysis. J Natl Cancer Inst (2000) 1.86
Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Cancer Res (1984) 1.83
Dust mite proteolytic allergens induce cytokine release from cultured airway epithelium. J Immunol (1998) 1.73
Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon. Proc Natl Acad Sci U S A (1984) 1.72
Properties of an oncornavirus glycoprotein: evidence for its presence on the surface of virions and infected cells. Virology (1973) 1.71
Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res (1991) 1.65
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. Am J Obstet Gynecol (1984) 1.60
Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2. Eur J Cancer (2004) 1.60
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology (1997) 1.58
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing. Eur Heart J (2003) 1.55
High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology (1981) 1.55
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet (1997) 1.53
Immunodiagnosis of hepatitis B with high-affinity IgM monoclonal antibodies. Proc Natl Acad Sci U S A (1981) 1.48
Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists. Proc Natl Acad Sci U S A (1996) 1.48
Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer (2000) 1.47
Identification and ratings of caricatures: implications for mental representations of faces. Cogn Psychol (1987) 1.46
Assessment of feline blood for transfusion purposes in the Dublin area of Ireland. Vet Rec (2011) 1.46
Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol (2000) 1.44
Differentiation in throat cultures of group C and G streptococci from Streptococcus milleri with identical antigens. Eur J Clin Microbiol (1984) 1.43
Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. Hum Mol Genet (1996) 1.42
Atomic-scale visualization of inertial dynamics. Science (2005) 1.42
Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank. Int J Cancer (1984) 1.42
Prolonged survival and remyelination after hematopoietic cell transplantation in the twitcher mouse. Science (1984) 1.39
Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res (1992) 1.38
Outcome of fetal ventriculomegaly. Lancet (1984) 1.35
Ethics and pharmaceutical medicine -- the full report of the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract (2006) 1.34
Activation of muscle-specific actin genes in Xenopus development by an induction between animal and vegetal cells of a blastula. Cell (1985) 1.33
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen. Am J Obstet Gynecol (1984) 1.30
Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood (2001) 1.30
Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas. Cancer Res (1986) 1.29
Relationship between the oncornavirus gene product gp70 and a major protein secretion of the mouse genital tract. Nature (1976) 1.28
The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans. Infection (1983) 1.28
Guiding Principles for Pharmaceutical Physicians from the Ethical Issues Committee of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the UK. Int J Clin Pract (2006) 1.25
Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group. Leukemia (2000) 1.25
Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde. QJM (2001) 1.24
The epidemiological type identification of Serratia marcescens from outbreaks of infection in hospitals. J Hyg (Lond) (1980) 1.24
Regulation of T-cell function by antibodies: enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies. Proc Natl Acad Sci U S A (1984) 1.20
Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Pathol (1982) 1.19
Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res (2000) 1.19
Specific high-affinity saturable binding of [3H] R05-4864 to benzodiazepine binding sites in the rat cerebral cortex. Eur J Pharmacol (1981) 1.19
Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer (1998) 1.19
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis. Eur Respir J (2008) 1.18
Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun (1991) 1.16
Reducing sleep disruptions in young children: evaluation of therapist-guided and written information approaches: a brief report. J Child Psychol Psychiatry (1989) 1.16
Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease. Am J Obstet Gynecol (1988) 1.16
Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods. J Clin Microbiol (1983) 1.16
Transcription of muscle-specific actin genes in early Xenopus development: nuclear transplantation and cell dissociation. Cell (1984) 1.15
HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection. J Virol (2008) 1.13
Reversible hypophosphatemic rickets following ifosfamide treatment. Med Pediatr Oncol (1992) 1.13
Clocking femtosecond X rays. Phys Rev Lett (2005) 1.13
Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol (2003) 1.12
O serotyping scheme for Enterobacter cloacae. J Clin Microbiol (1983) 1.12
Diltiazem enhancement of [3H]nitrendipine binding to calcium channel associated drug receptor sites in rat brain synaptosomes. Biochem Biophys Res Commun (1982) 1.11
Sudden blindness in a child: presenting symptom of a sphenoid sinus mucocele. Br J Ophthalmol (1992) 1.10
Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus. Nature (1982) 1.09
FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation (1999) 1.09
Improved processing technique for renal biopsies for light microscopy. J Clin Pathol (1970) 1.08
Infantile fibrosarcoma. Med Pediatr Oncol (1991) 1.07
Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol (1986) 1.07
The CA 125 assay as a predictor of clinical recurrence in epithelial ovarian cancer. Am J Obstet Gynecol (1986) 1.06
Specific high-affinity binding sites for [3H]Ro 5-4864 in rat brain and kidney. J Pharmacol Exp Ther (1983) 1.05
Case series: 2q33.1 microdeletion syndrome--further delineation of the phenotype. J Med Genet (2011) 1.05
Comparison of IgE and IgG antibody-dependent cytotoxicity in vitro and in a SCID mouse xenograft model of ovarian carcinoma. Eur J Immunol (1999) 1.05
Cystic fibrosis genotyping by direct PCR analysis of Guthrie blood spots. PCR Methods Appl (1992) 1.05
Complete detection of mutations in cystic fibrosis patients of Native American origin. Hum Genet (1994) 1.04
Iodination of monoclonal antibodies for diagnosis and radiotherapy using a convenient one vial method. J Nucl Med (1986) 1.04
Short-term regulation of bile acid uptake by microfilament-dependent translocation of rat ntcp to the plasma membrane. Hepatology (1999) 1.03
An essential role for Rac/Cdc42 GTPases in cerebellar granule neuron survival. J Biol Chem (2001) 1.02
Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex. AIDS (1987) 1.01
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma. Gynecol Oncol (1985) 1.01
New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency. Cancer Res (1994) 1.00
In vitro response to HBsAg of peripheral blood lymphocytes from recipients of hepatitis B vaccine. Hepatology (1984) 1.00
Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen. Proc Natl Acad Sci U S A (1982) 0.99
Zinc status of pregnant alcoholic women: a determinant of fetal outcome. Lancet (1981) 0.99
Busulfan pharmacokinetics following intravenous and oral dosing regimens in children receiving high-dose myeloablative chemotherapy for high-risk neuroblastoma as part of the HR-NBL-1/SIOPEN trial. Eur J Cancer (2012) 0.99
Isolation, properties, and structure of human IgA myeloma globulins. Adv Exp Med Biol (1974) 0.99
CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Oncogene (1995) 0.98
Production of antibody to tetanus toxoid by continuous human lymphoblastoid cell lines. Science (1978) 0.98
CA 125 in gynecologic practice. Am J Obstet Gynecol (1986) 0.97
SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors. J Pharmacol Exp Ther (2001) 0.97